The human cytomegalovirus glycoprotein gp68 functions as an Fc receptor for host IgGs and can form antibody bipolar bridging (ABB) complexes in which gp68 binds the Fc region of an antigen-bound IgG. Here we show that gp68-mediated endocytosis transports ABB complexes into endosomes, after which the complex is routed to lysosomes, presumably for degradation. These results suggest gp68 contributes to evasion of IgG-mediated immune responses by mediating destruction of host IgG and viral antigens.
T
he betaherpesvirus human cytomegalovirus (HCMV) affects 50 to 98% of people, causing severe symptoms in newborns and a lifetime latent infection that can be lethal in immunocompromised individuals (1) . HCMV can also establish recurrent secondary infections after reactivation from latency (2) . Immune evasion strategies of herpesviruses include expression of viral Fc receptors (Fc␥Rs) that bind host IgG to evade immune responses mediated by host Fc␥Rs (3) (4) (5) (6) . Viral Fc␥Rs can participate in antibody bipolar bridging (ABB), whereby an antibody simultaneously binds antigen via its fragment antigen-binding (Fab) arms and an Fc receptor using its Fc (7) (8) (9) . While there is likely a large excess of nonviral IgG compared with antiviral IgG, the proximity of viral Fc␥Rs to Fc regions from IgGs bound to viral antigens on an infected cell could allow viral Fc␥Rs to preferentially bind antiviral IgGs. ABB protects virally infected cells from antibodyand complement-dependent neutralization (10), antibody-dependent cell-mediated cytotoxicity (11) , and granulocyte attachment (12) . The HCMV glycoproteins gp68, gp34, Toll-like receptor 12 (TLR12), and TLR13 act as Fc␥Rs to bind human IgG (3, 6, 13, 14) . Recent studies reported formation of ABB complexes with gp68 and with gp34 and demonstrated their functional importance by showing that cells infected with HCMV lacking gp68 and/or gp34 triggered stronger activation of the host Fc␥Rs and NK cells than cells infected with wildtype HCMV (15) .
In previous studies of ABB, we used cells expressing gE-gI, a herpes simplex virus 1 (HSV-1) Fc␥R, and gD, an HSV-1 cell surface antigen, to show that anti-gD IgGs formed ABB complexes with gE-gI and gD and that anti-gD IgG and gD were internalized in a gE-gI-dependent process, resulting in lysosomal localization of IgG and gD, but not gE-gI (8) (Fig. 1) . Since gE-gI binds Fc at neutral/basic, but not acidic, pH (8, 16) , these results were consistent with dissociation of IgG-antigen complexes from gE-gI upon trafficking to acidic intracellular vesicles. In contrast, the gp68-Fc interaction is broadly stable across acidic and basic pHs (17) , suggesting a potentially different intracellular trafficking pathway if gp68, like gE-gI, can internalize ABB complexes.
To investigate ABB mediated by HCMV gp68, we adapted the model system used to characterize gE-gI-mediated ABB (8) . In the gE-gI studies, we transiently expressed gE-gI and gD in HeLa cells and then investigated the trafficking of gE-gI and gD under ABB and non-ABB conditions (8) . We chose gD as the model antigen because it is a cell surface glycoprotein found on virions and infected cells (18) , and fusion of its cytoplasmic tail to a fluorescent protein did not affect cellular distribution or transport (19) . We showed that a gD-Dendra2 fusion protein localized primarily to the cell surface in the presence or absence of an anti-gD antibody under non-ABB conditions (8) ; thus, we could use this protein to investigate the fate of a cell surface antigen under ABB conditions. We used an anti-gD IgG antibody (20) with a human Fc (anti-gD hFc ) that can bind to gE-gI and to gD to create ABB complexes and two types of control IgGs to create non-ABB complexes: the anti-gD antibody fused with a mouse Fc (antigD mFc ), which binds gD, but not gE-gI; and a human IgG against an unrelated antigen (IgG hFc ), which binds gE-gI, but not gD (Fig. 1) . These IgGs were expressed in mammalian cells as described previously (8) . We found that gD expressed in gE-gI-positive cells was internalized together with anti-gD hFc , but it remained at the cell surface when cells were incubated with anti-gD mFc or IgG hFc (8) .
For the gp68 ABB system, we expressed gp68 together with the gD-Dendra2 fusion protein using a previously described bicistronic construct (8) . For control experiments, we also expressed untagged gp68 alone and as a gp68-Dendra2 fusion protein.
Three-dimensional (3D) imaging of fixed cells expressing untagged gp68 or gp68-Dendra2 showed comparable levels and localization of both proteins in experiments using labeled antigD hFc ( Fig. 2A ) and gp68-Dendra2 colocalized with IgG hFc in intracellular compartments (Fig. 3A) ; thus, the introduction of the C-terminal tag did not detectably affect Fc binding or the gp68 cellular distribution. Cells expressing gp68-Dendra2 bound anti-gD hFc and IgG hFc , but not anti-gD mFc (Fig. 2B) , consistent with previous reports that cells infected with wild-type HCMV bind human, but not mouse, IgG (21) . Together with previous demonstrations that both anti-gD hFc and anti-gD mFc bind gD (8), these results showed that the three forms of IgG could be used to create ABB or non-ABB conditions when gp68 was coexpressed with gD.
We next conducted internalization experiments using cells coexpressing gp68 and gD under ABB and non-ABB conditions (Fig.  1 ). Cells transiently expressing gp68 and gD-Dendra2 were incubated with fluorescently labeled IgGs (anti-gD hFc , anti-gD mFc , or IgG hFc ) and then stained with CellMask, a plasma membrane marker. As expected, the gp68-binding IgGs anti-gD hFc and IgG hFc were internalized after incubation with the cells, whereas anti-gD mFc remained at the cell surface, where it colocalized with gD and the membrane marker (Fig. 2C) . gD remained at the cell surface when cells were incubated with either anti-gD mFc or IgG hFc , as demonstrated by colocalization with CellMask at the plasma membrane, but was internalized when cells were incubated with anti-gD hFc (Fig. 2C and D) . Thus, as previously found for the gE-gI studies (8) , gD was internalized through indirect interactions with the receptor as an IgG-antigen complex under ABB conditions, whereas when the IgG bound only to gD (anti-gD mFc ) or the viral Fc␥R (IgG hFc ), gD remained at the cell surface.
We performed live-cell four-dimensional (4D) confocal imaging to follow the intracellular trafficking of ABB complex components using labeled epidermal growth factor (EGF) as a lysosomal marker. EGF binds its cell surface receptor prior to being internalized and transported through the acidic environment of early endosomes, multivesicular bodies/late endosomes, and lysosomes (22) (23) (24) (25) . HeLa cells expressing gp68 and gD-Dendra2 were coincubated with fluorescently labeled EGF and a labeled version of either anti-gD hFc , IgG hFc , or anti-gD mFc . At early time points in samples incubated with anti-gD hFc , gD, and EGF, anti-gD hFc fluorescence was primarily localized at the cell surface, and the small amount of intracellular gD and anti-gD hFc fluorescence was not found in EGF-positive compartments. At later time points, increasing numbers of triple-positive intracellular vesicles staining for EGF, gD, and anti-gD hFc were observed ( Fig. 3B to D ; see Movie S1 in the supplemental material). These results are consistent with a model in which gp68 -anti-gD hFc -gD ABB complexes are internalized into endosomes and remain associated at low pH such that they traffic together into EGF-positive lysosomes (Fig.  1) . Under non-ABB conditions, gD fluorescence remained predominantly at the cell surface at all time points in gp68/gD-positive cells treated with either IgG hFc or anti-gD mFc ( Fig. 3B to D; see Movies S2 and S3 in the supplemental material). Internalized IgG hFc fluorescence was found mainly in EGF-negative compartments at early time points (10 min) and then in EGF-positive compartments at later time points (60 min). Statistical analyses of pairwise 3D colocalization as a function of time (Fig. 3C) demonstrated colocalization of gD with the two anti-gD antibodies, but not with IgG hFc , at time points after 10 min, as expected since only the anti-gD antibodies bind to gD throughout the experiment (Fig. 3C and D) . When incubated with anti-gD hFc , gD became increasingly more colocalized with EGF and anti-gD hFc , whereas when incubated with IgG hFc , EGF colocalized with IgG hFc , but not gD, at later time points. When incubated with anti-gD mFc , gD did not colocalize with EGF. These results demonstrated that cell surface gD was exclusively internalized and targeted into EGF-positive lysosomes under ABB conditions, consistent with a model in which gp68 -anti-gD hFc -gD ABB complexes and gp68-IgG hFc complexes are internalized into endosomal vesicles and remain associated at low pH such that they traffic together into EGFpositive lysosomes, whereas anti-gD mFc remained attached to cell surface gD because it did not bind to gp68. We repeated the internalization experiments in fixed cells using LAMP2A as a lysosomal marker (26) . Cells expressing gp68 and gD-Dendra2 were incubated for 2 h with labeled anti-gD hFc , IgG hFc , or anti-gD mFc ,
FIG 1 Schematic diagrams of ABB and non-ABB complexes at a cell surface
and comparison of intracellular trafficking of gE-gI-and gp68-mediated ABB complexes. (Top) ABB complex containing gp68, anti-gD hFc , and gD (left) and non-ABB complexes containing IgG hFc bound to gp68, but not gD (middle), and anti-gD mFc bound to gD, but not gp68 (right). (Bottom) Proposed pathways for intracellular trafficking of ABB complexes. Cell surface ABB complexes are internalized through endocytosis into early endosomes and sorting endosomes. Upon acidification, the Fabs remain bound to gD, and the Fc region of anti-gD hFc dissociates from HSV1-gE-gI, but not from HCMV gp68. The IgG-gD complex internalized with gE-gI, and the IgG-gD-gp68 complex then traffics to degradative lysosomes, allowing free gE-gI, but not gp68, to be recycled back to the cell surface.
immunostained with anti-LAMP2A, and 3D confocal imaging and statistical analyses of pairwise colocalizations were performed. Consistent with lysosomal routing of ABB complexes, cells incubated with anti-gD hFc showed three pairwise colocalizations (gD with anti-gD hFc , gD with LAMP2A, and anti-gD hFc with LAMP2A), cells incubated with IgG hFc showed single colocalization (IgG hFc with LAMP2A), and cells incubated with anti-gD mFc also showed single colocalization (gD with antigD mFc ) (Fig. 4) .
Here we investigated the fate of HCMV gp68-mediated ABB complexes using techniques developed for studying ABB mediated by HSV-1 gE-gI (8) . We found that, like gE-gI, gp68 formed ABB complexes with anti-gD hFc and gD, resulting in internalization of gD. The internalization required gp68-mediated ABB, since it occurred only in the presence of the IgG that could bind to both gp68 and gD, but not in the presence of the anti-gD mFc and IgG hFc control antibodies. However, the ABB complexes formed with gp68, IgG, and gD apparently did not dissociate after endocytosis; instead all three components were trafficked to lysosomes, where they were presumably degraded (Fig. 1) . Extrapolation of these results to virally infected cells provides a mechanism by which infected cells can sequester both host antiviral antibodies and their viral antigen targets from the host immune system by targeting them for degradation in lysosomes. In the case of HCMV gp68, the cotrafficking of the viral Fc␥R to lysosomes together with the IgG-antigen complex should also result in degradation of the receptor, whereas dissociation of gE-gI from the IgG-antigen complex prior to entering lysosomes would allow gE-gI to be recycled back to the cell surface. The postulated differences in trafficking resulting in degradation of gp68, but not gE-gI, may reflect the fact that HCMV expresses at least three different IgG Fc binding proteins (3, 13, 14) , compared with HSV-1, which expresses only one known Fc␥R (5, 11). For both viruses, internalization of ABB complexes and consequent degradation would enable clearance of membrane proteins that serve as antigenic targets and selective removal of antiviral antibodies, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
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